Selected research
Industry Research
Megestrol Acetate (Megace) Industry Research Report 2026
Market perspective
The global Megestrol Acetate (Megace) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Megestrol Acetate (Megace) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Megestrol Acetate (Megace) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Megestrol Acetate (Megace) include Actiza Pharmaceutical, Apotex Corporation, Breckenridge Pharmaceutical, Hikma (West-ward Pharm, Roxane Labs..), Hi-tech Pharmacal (Akorn), Morton Grove Pharmaceutical, Par Pharmaceutical (Endo International), TWi Pharmaceuticals and Jiangsu Nhwa Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Megestrol Acetate (Megace) market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Megestrol Acetate (Megace) Market by Company
Actiza Pharmaceutical
Apotex Corporation
Breckenridge Pharmaceutical
Hikma (West-ward Pharm, Roxane Labs..)
Hi-tech Pharmacal (Akorn)
Morton Grove Pharmaceutical
Par Pharmaceutical (Endo International)
TWi Pharmaceuticals
Jiangsu Nhwa Pharmaceutical
Nanjing Cuccess Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Teva Pharmaceuticals
Grand Deten Pharmaceutical
Xianju pharma
Megestrol Acetate (Megace) Segment by Type
Suspension
Tablets
Megestrol Acetate (Megace) Segment by Application
Hospital
Clinic
Other
Megestrol Acetate (Megace) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol Acetate (Megace) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Megestrol Acetate (Megace) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol Acetate (Megace).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Megestrol Acetate (Megace) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Megestrol Acetate (Megace) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Suspension
- Tablets
Applications
- Hospital
- Clinic
- Other
Companies covered
- Actiza Pharmaceutical
- Apotex Corporation
- Breckenridge Pharmaceutical
- Hikma (West-ward Pharm, Roxane Labs..)
- Hi-tech Pharmacal (Akorn)
- Morton Grove Pharmaceutical
- Par Pharmaceutical (Endo International)
- TWi Pharmaceuticals
- Jiangsu Nhwa Pharmaceutical
- Nanjing Cuccess Pharmaceutical
- Qingdao Guohai Biological Pharmaceutical
- Teva Pharmaceuticals
- Grand Deten Pharmaceutical
- Xianju pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Megestrol Acetate (Megace) Market Size (2021-2032)
- 2.2.2 Global Megestrol Acetate (Megace) Sales (2021-2032)
- 2.2.3 Global Megestrol Acetate (Megace) Market Average Price (2021-2032)
- 2.3 Megestrol Acetate (Megace) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Suspension
- 2.3.3 Tablets
- 2.4 Megestrol Acetate (Megace) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Megestrol Acetate (Megace) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Megestrol Acetate (Megace) Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Megestrol Acetate (Megace) Revenue of Manufacturers (2021-2026)
- 3.4 Global Megestrol Acetate (Megace) Average Price by Manufacturers (2021-2026)
- 3.5 Global Megestrol Acetate (Megace) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Megestrol Acetate (Megace), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Megestrol Acetate (Megace), Product Type & Application
- 3.8 Global Manufacturers of Megestrol Acetate (Megace), Established Date
- 3.9 Global Megestrol Acetate (Megace) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actiza Pharmaceutical
- 4.1.1 Actiza Pharmaceutical Company Information
- 4.1.2 Actiza Pharmaceutical Business Overview
- 4.1.3 Actiza Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.1.5 Actiza Pharmaceutical Recent Developments
- 4.2 Apotex Corporation
- 4.2.1 Apotex Corporation Company Information
- 4.2.2 Apotex Corporation Business Overview
- 4.2.3 Apotex Corporation Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Corporation Megestrol Acetate (Megace) Product Portfolio
- 4.2.5 Apotex Corporation Recent Developments
- 4.3 Breckenridge Pharmaceutical
- 4.3.1 Breckenridge Pharmaceutical Company Information
- 4.3.2 Breckenridge Pharmaceutical Business Overview
- 4.3.3 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.3.5 Breckenridge Pharmaceutical Recent Developments
- 4.4 Hikma (West-ward Pharm, Roxane Labs..)
- 4.4.1 Hikma (West-ward Pharm, Roxane Labs..) Company Information
- 4.4.2 Hikma (West-ward Pharm, Roxane Labs..) Business Overview
- 4.4.3 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio
- 4.4.5 Hikma (West-ward Pharm, Roxane Labs..) Recent Developments
- 4.5 Hi-tech Pharmacal (Akorn)
- 4.5.1 Hi-tech Pharmacal (Akorn) Company Information
- 4.5.2 Hi-tech Pharmacal (Akorn) Business Overview
- 4.5.3 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio
- 4.5.5 Hi-tech Pharmacal (Akorn) Recent Developments
- 4.6 Morton Grove Pharmaceutical
- 4.6.1 Morton Grove Pharmaceutical Company Information
- 4.6.2 Morton Grove Pharmaceutical Business Overview
- 4.6.3 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.6.5 Morton Grove Pharmaceutical Recent Developments
- 4.7 Par Pharmaceutical (Endo International)
- 4.7.1 Par Pharmaceutical (Endo International) Company Information
- 4.7.2 Par Pharmaceutical (Endo International) Business Overview
- 4.7.3 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio
- 4.7.5 Par Pharmaceutical (Endo International) Recent Developments
- 4.8 TWi Pharmaceuticals
- 4.8.1 TWi Pharmaceuticals Company Information
- 4.8.2 TWi Pharmaceuticals Business Overview
- 4.8.3 TWi Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 4.8.5 TWi Pharmaceuticals Recent Developments
- 4.9 Jiangsu Nhwa Pharmaceutical
- 4.9.1 Jiangsu Nhwa Pharmaceutical Company Information
- 4.9.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 4.9.3 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.9.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 4.10 Nanjing Cuccess Pharmaceutical
- 4.10.1 Nanjing Cuccess Pharmaceutical Company Information
- 4.10.2 Nanjing Cuccess Pharmaceutical Business Overview
- 4.10.3 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.10.5 Nanjing Cuccess Pharmaceutical Recent Developments
- 4.11 Qingdao Guohai Biological Pharmaceutical
- 4.11.1 Qingdao Guohai Biological Pharmaceutical Company Information
- 4.11.2 Qingdao Guohai Biological Pharmaceutical Business Overview
- 4.11.3 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.11.5 Qingdao Guohai Biological Pharmaceutical Recent Developments
- 4.12 Teva Pharmaceuticals
- 4.12.1 Teva Pharmaceuticals Company Information
- 4.12.2 Teva Pharmaceuticals Business Overview
- 4.12.3 Teva Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 4.12.5 Teva Pharmaceuticals Recent Developments
- 4.13 Grand Deten Pharmaceutical
- 4.13.1 Grand Deten Pharmaceutical Company Information
- 4.13.2 Grand Deten Pharmaceutical Business Overview
- 4.13.3 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 4.13.5 Grand Deten Pharmaceutical Recent Developments
- 4.14 Xianju pharma
- 4.14.1 Xianju pharma Company Information
- 4.14.2 Xianju pharma Business Overview
- 4.14.3 Xianju pharma Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Xianju pharma Megestrol Acetate (Megace) Product Portfolio
- 4.14.5 Xianju pharma Recent Developments
5 Global Megestrol Acetate (Megace) Market Scenario by Region
- 5.1 Global Megestrol Acetate (Megace) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Megestrol Acetate (Megace) Sales by Region: 2021-2032
- 5.2.1 Global Megestrol Acetate (Megace) Sales by Region: 2021-2026
- 5.2.2 Global Megestrol Acetate (Megace) Sales by Region: 2027-2032
- 5.3 Global Megestrol Acetate (Megace) Revenue by Region: 2021-2032
- 5.3.1 Global Megestrol Acetate (Megace) Revenue by Region: 2021-2026
- 5.3.2 Global Megestrol Acetate (Megace) Revenue by Region: 2027-2032
- 5.4 North America Megestrol Acetate (Megace) Market Facts & Figures by Country
- 5.4.1 North America Megestrol Acetate (Megace) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 5.4.3 North America Megestrol Acetate (Megace) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Megestrol Acetate (Megace) Market Facts & Figures by Country
- 5.5.1 Europe Megestrol Acetate (Megace) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 5.5.3 Europe Megestrol Acetate (Megace) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Megestrol Acetate (Megace) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Megestrol Acetate (Megace) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Megestrol Acetate (Megace) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Megestrol Acetate (Megace) Market Facts & Figures by Country
- 5.7.1 South America Megestrol Acetate (Megace) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 5.7.3 South America Megestrol Acetate (Megace) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Megestrol Acetate (Megace) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Megestrol Acetate (Megace) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Megestrol Acetate (Megace) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Megestrol Acetate (Megace) Sales by Type (2021-2032)
- 6.1.1 Global Megestrol Acetate (Megace) Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Megestrol Acetate (Megace) Sales Market Share by Type (2021-2032)
- 6.2 Global Megestrol Acetate (Megace) Revenue by Type (2021-2032)
- 6.2.1 Global Megestrol Acetate (Megace) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Megestrol Acetate (Megace) Revenue Market Share by Type (2021-2032)
- 6.3 Global Megestrol Acetate (Megace) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Megestrol Acetate (Megace) Sales by Application (2021-2032)
- 7.1.1 Global Megestrol Acetate (Megace) Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Megestrol Acetate (Megace) Sales Market Share by Application (2021-2032)
- 7.2 Global Megestrol Acetate (Megace) Revenue by Application (2021-2032)
- 7.2.1 Global Megestrol Acetate (Megace) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Megestrol Acetate (Megace) Revenue Market Share by Application (2021-2032)
- 7.3 Global Megestrol Acetate (Megace) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Megestrol Acetate (Megace) Value Chain Analysis
- 8.1.1 Megestrol Acetate (Megace) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Megestrol Acetate (Megace) Production Mode & Process
- 8.2 Megestrol Acetate (Megace) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Megestrol Acetate (Megace) Distributors
- 8.2.3 Megestrol Acetate (Megace) Customers
9 Global Megestrol Acetate (Megace) Analyzing Market Dynamics
- 9.1 Megestrol Acetate (Megace) Industry Trends
- 9.2 Megestrol Acetate (Megace) Industry Drivers
- 9.3 Megestrol Acetate (Megace) Industry Opportunities and Challenges
- 9.4 Megestrol Acetate (Megace) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst